Cargando…
Targeted therapies for lung cancer: how did the game begin?
Landmark studies on genetic alterations underlying NSCLC have led to tailored therapies http://ow.ly/4nq0Ps
Autores principales: | Kanellakis, Nikolaos I., Jacinto, Tiago, Psallidas, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933615/ https://www.ncbi.nlm.nih.gov/pubmed/27408637 http://dx.doi.org/10.1183/20734735.006316 |
Ejemplares similares
-
Management of incidental nodules in lung cancer screening: ready for prime-time?
por: Kanellakis, Nikolaos I., et al.
Publicado: (2019) -
Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
por: Guariglia, Andrea, et al.
Publicado: (2020) -
Doing science: How to submit a successful funding application
por: Hardavella, Georgia, et al.
Publicado: (2016) -
How to optimise patient and public involvement in your research: Doing science
por: Hardavella, Georgia, et al.
Publicado: (2015) -
Doing science: how to get credit for your scientific work
por: Caudri, Daan, et al.
Publicado: (2015)